Effects of hormones on development of fetal enzymes

Inhibition of hendra virus fusion.

Journal of virology·2006

Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.

Journal of virology·2001

A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.

Journal of virology·2001

Mechanism of interference mediated by human parainfluenza virus type 3 infection.

Journal of virology·2000

The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.

Journal of virology·2000

The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.

Virology·1999

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

Clinical pharmacology and therapeutics·2026

Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.

Clinical pharmacology and therapeutics·2026

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions.

Clinical pharmacology and therapeutics·2026

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Clinical pharmacology and therapeutics·2026

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Clinical pharmacology and therapeutics·2026

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

Clinical pharmacology and therapeutics·2026

Prediction of growth abnormalities in monochorionic diamniotic twin pregnancies using estimated fetal weight discordance and clinical factors: a retrospective cohort study.

Journal of perinatal medicine·2026

Clinical evaluation and predictive model development of AI-based non-invasive embryo selection in in vitro fertilization patients.

Frontiers in endocrinology·2026

Clinical pregnancy, live birth, and twin pregnancy outcomes of nine frozen-thawed embryo transfer strategies across female age groups: a real-world cohort study.

Frontiers in endocrinology·2026

Association of miRNA (miR-10a, miR-30c, miR-181a, and miR-499b) Polymorphisms and Their Interactions with PAI-1 in Recurrent Implantation Failure in Korean Women.

Reproductive sciences (Thousand Oaks, Calif.)·2026

Hepatic estrogen receptor α contributes to stage-specific coupling of liver metabolism and proliferation during pregnancy.

Metabolism: clinical and experimental·2026

Reproductive safety of direct oral anticoagulants after maternal exposure in early pregnancy: a comparative ENTIS cohort study.

Journal of thrombosis and haemostasis : JTH·2026

Related Experiment Videos

Effects of hormones on development of fetal enzymes

Related Concept Videos

Inhibition of hendra virus fusion.

Human parainfluenza virus type 3 HN-receptor interaction: effect of 4-guanidino-Neu5Ac2en on a neuraminidase-deficient variant.

A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity.

Mechanism of interference mediated by human parainfluenza virus type 3 infection.

The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.

The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3.

Exposure-Response Analyses of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Advanced Non-small Cell Lung Cancer.

Exposure-Response Analysis of Enfortumab Vedotin Plus Pembrolizumab as First-Line Therapy for Locally Advanced or Metastatic Urothelial Cancer.

How to Optimize Healthy Volunteer Screening and Enrolment in Clinical Trials: A Qualitative and Quantitative Approach to Evaluate Processes and Healthy Volunteers' Perceptions.

Phase I Evaluation of Siltartoxatug, a First-in-Class Anti-Tetanus Monoclonal Antibody: Safety, Pharmacokinetics and Pharmacodynamics in Healthy Australian and Chinese Populations.

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.

Prediction of growth abnormalities in monochorionic diamniotic twin pregnancies using estimated fetal weight discordance and clinical factors: a retrospective cohort study.

Clinical evaluation and predictive model development of AI-based non-invasive embryo selection in in vitro fertilization patients.

Clinical pregnancy, live birth, and twin pregnancy outcomes of nine frozen-thawed embryo transfer strategies across female age groups: a real-world cohort study.

Association of miRNA (miR-10a, miR-30c, miR-181a, and miR-499b) Polymorphisms and Their Interactions with PAI-1 in Recurrent Implantation Failure in Korean Women.

Hepatic estrogen receptor α contributes to stage-specific coupling of liver metabolism and proliferation during pregnancy.

Reproductive safety of direct oral anticoagulants after maternal exposure in early pregnancy: a comparative ENTIS cohort study.

Related Experiment Videos

Effects of hormones on development of fetal enzymes

Related Concept Videos

Related Articles